Stock Track | JD Health Soars 5.01% Intraday on Strategic Partnership with Everest Medicines

Stock Track
07/16

JD Health's stock soared 5.01% during intraday trading on Thursday, reflecting significant investor interest.

The surge follows the announcement of a strategic cooperation agreement between JD Health and biopharmaceutical company Everest Medicines. The partnership will focus on innovative drug new product launches, patient services, digital marketing, and internet healthcare, with Everest Medicines prioritizing its new products on the JD Health platform to improve drug accessibility and service quality.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10